OXTHERA
LIVE

Serial Number

88576540

Owner

OXTHERA INTELLECTUAL PROPERTY AB

Attorney

Donna J. Bunton

Filing Date

Aug 13, 2019

Add to watchlist:

No watchlists yet
View on USPTO

OXTHERA Trademark

Serial Number: 88576540 • Registration: 6458608

OXTHERA is a trademark filed by OXTHERA INTELLECTUAL PROPERTY AB on August 13, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

OXTHERA INTELLECTUAL PROPERTY AB (8 trademarks)

STUREGATAN 56
S114 36 STOCKHOLM , SE

Entity Type: 11

Trademark Details

Filing Date

August 13, 2019

Registration Date

August 24, 2021

Published for Opposition

June 8, 2021

Goods & Services

Pharmaceutical preparations for use in urology, nephrology, gastroenterology, oncology and immunology and for the treatment of diabetes, infectious diseases, inflammation and metabolic diseases, all for therapeutic use; pharmaceutical preparations for the treatment of kidney stones; pharmaceutical products for the treatment and prevention of kidney diseases in patients with hyperoxaluria

Retail store services featuring goods in the fields of pharmaceuticals, medical preparations, vaccines, natural remedies, diagnostics and medical devices; goods import-export agencies; sales promotion for others in the fields of pharmaceuticals, medical preparations, vaccines, natural remedies, diagnostics and medical devices

Scientific and technological services, namely, research and design in the fields of pharmaceutics, tissue engineering and regenerative medicine; analysis of industrial fluids and scientific research services; medical, biological, chemical and scientific research; industrial research in the fields of pharmaceutics, tissue engineering and regenerative medicine; pharmaceutical research and development; research and development of new products in the nature of new medicines and medical preparations; medical and chemical laboratories; clinical testing, namely, conducting clinical trials for others in the fields of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy; development of new products in the nature of probes, reagents and bioassays for industrial and scientific purposes; advisory, consultancy and information services relating to the provision of the aforesaid mentioned services, namely, advisory and consultancy services relating to medical, biological, chemical and scientific research, industrial research in the fields of pharmaceutics, tissue engineering and regenerative medicine, pharmaceutical research and development and conducting clinical trials and providing information in the fields of medical research, biological research, chemical research, scientific research and industrial research in the fields of pharmaceutics, tissue engineering and regenerative medicine

Filing History

REGISTERED-PRINCIPAL REGISTER
Aug 24, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 8, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 8, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 19, 2021 NONP
ELECTRONIC RECORD REVIEW COMPLETE
May 3, 2021 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 30, 2021 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 29, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 29, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 29, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 29, 2021 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 29, 2021 ZZZX
CASE RETURNED TO EXAMINATION
Apr 29, 2021 OTHE
NOTICE OF ALLOWANCE CANCELLED
Apr 29, 2021 IUCN
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Apr 15, 2021 PCBG
ASSIGNED TO PETITION STAFF
Apr 12, 2021 APET
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 12, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jan 11, 2021 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 11, 2021 AITU
SOU EXTENSION 1 FILED
Dec 23, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 23, 2020 EEXT
TEAS PETITION TO DIRECTOR RECEIVED
Dec 23, 2020 TPDR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 30, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2020 NONP
ASSIGNED TO LIE
Mar 26, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 20, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 20, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 20, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 20, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 20, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 19, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 19, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 19, 2020 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 21, 2020 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 21, 2020 CHAN
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 21, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 21, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 21, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 21, 2020 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 19, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 19, 2019 GNRT
NON-FINAL ACTION WRITTEN
Nov 19, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 13, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 29, 2019 NWOS
NEW APPLICATION ENTERED
Aug 16, 2019 NWAP